Suppr超能文献

结直肠癌的分子发病机制及其在结直肠癌筛查中的潜在应用。

The molecular pathogenesis of colorectal cancer and its potential application to colorectal cancer screening.

作者信息

Grady William M, Markowitz Sanford D

机构信息

Clinical Research Division, Fred Hutchison Cancer Research Center, 1100 Fairview Avenue N., D4-100, Seattle, WA, 98109, USA,

出版信息

Dig Dis Sci. 2015 Mar;60(3):762-72. doi: 10.1007/s10620-014-3444-4. Epub 2014 Dec 10.

Abstract

INTRODUCTION

Advances in our understanding of the molecular genetics and epigenetics of colorectal cancer have led to novel insights into the pathogenesis of this common cancer. These advances have revealed that there are molecular subtypes of colon polyps and colon cancer and that these molecular subclasses have unique and discrete clinical and pathological features. Although the molecular characterization of these subgroups of colorectal polyps and cancer is only partially understood at this time, it does appear likely that classifying colon polyps and cancers based on their genomic instability and/or epigenomic instability status will eventually be useful for informing approaches for the prevention and early detection of colon polyps and colorectal cancer.

CONCLUSIONS

In this review, we will discuss our current understanding of the molecular pathogenesis of the polyp to cancer sequence and the potential to use this information to direct screening and prevention programs.

摘要

引言

我们对结直肠癌分子遗传学和表观遗传学认识的进展,为深入了解这种常见癌症的发病机制带来了新见解。这些进展表明,结肠息肉和结肠癌存在分子亚型,且这些分子亚类具有独特且离散的临床和病理特征。尽管目前对结直肠息肉和癌症这些亚组的分子特征仅部分了解,但基于基因组不稳定性和/或表观基因组不稳定性状态对结肠息肉和癌症进行分类,最终可能有助于为结肠息肉和结直肠癌的预防及早期检测方法提供依据。

结论

在本综述中,我们将讨论目前对息肉到癌症序列分子发病机制的理解,以及利用这些信息指导筛查和预防计划的潜力。

相似文献

1
The molecular pathogenesis of colorectal cancer and its potential application to colorectal cancer screening.
Dig Dis Sci. 2015 Mar;60(3):762-72. doi: 10.1007/s10620-014-3444-4. Epub 2014 Dec 10.
2
[Genetics and molecular classification of colorectal cancer].
Tidsskr Nor Laegeforen. 2007 Nov 1;127(21):2818-23.
3
Approach to colon polyps in the elderly.
Am J Gastroenterol. 2000 May;95(5):1147-51. doi: 10.1111/j.1572-0241.2000.02001.x.
5
Pathology of premalignant colorectal neoplasia.
Dig Endosc. 2016 Apr;28(3):312-23. doi: 10.1111/den.12633. Epub 2016 Mar 15.
6
Update on colorectal cancer.
Am Fam Physician. 2000 Mar 15;61(6):1759-70, 1773-4.
8
Colon polyps and cancer.
Endoscopy. 2003 Jan;35(1):27-35. doi: 10.1055/s-2003-36410.
9
Molecular pathogenesis of colorectal cancer: implications for molecular diagnosis.
Cancer. 2005 Nov 15;104(10):2035-47. doi: 10.1002/cncr.21462.
10
Colon Capsule Endoscopy for the Detection of Colorectal Polyps: An Evidence-Based Analysis.
Ont Health Technol Assess Ser. 2015 Jul 1;15(14):1-39. eCollection 2015.

引用本文的文献

1
The impact of genetics and the environment on cancer risk in Indigenous Australians: a narrative review.
Lancet Reg Health West Pac. 2025 Jun 29;61:101627. doi: 10.1016/j.lanwpc.2025.101627. eCollection 2025 Aug.
2
Advances in the diagnosis of colorectal cancer: the application of molecular biomarkers and imaging techniques: a literature review.
Ann Med Surg (Lond). 2025 Jan 9;87(1):192-203. doi: 10.1097/MS9.0000000000002830. eCollection 2025 Jan.
3
Colorectal cancer: local results and significance in Hungary.
J Gastrointest Oncol. 2024 Dec 31;15(6):2552-2577. doi: 10.21037/jgo-24-318. Epub 2024 Dec 28.
4
LncRNA MALAT1 as diagnostic and prognostic biomarker in colorectal cancers: A systematic review and meta-analysis.
PLoS One. 2024 Oct 29;19(10):e0308009. doi: 10.1371/journal.pone.0308009. eCollection 2024.
6
Innovations in colorectal cancer treatment: trifluridine and tipiracil with bevacizumab for improved outcomes - a review.
Front Oncol. 2024 Jul 12;14:1296765. doi: 10.3389/fonc.2024.1296765. eCollection 2024.
9
10
Effects of sigmoidoscopy screening (including colonoscopy) on colorectal cancer: A -analysis based on randomized controlled trials.
Prev Med Rep. 2024 Feb 1;39:102636. doi: 10.1016/j.pmedr.2024.102636. eCollection 2024 Mar.

本文引用的文献

2
Modulation of age- and cancer-associated DNA methylation change in the healthy colon by aspirin and lifestyle.
J Natl Cancer Inst. 2014 Jun 28;106(7). doi: 10.1093/jnci/dju161. Print 2014 Jul.
3
Synchronous colorectal cancer: clinical, pathological and molecular implications.
World J Gastroenterol. 2014 Jun 14;20(22):6815-20. doi: 10.3748/wjg.v20.i22.6815.
4
Progress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions.
Am J Gastroenterol. 2014 Aug;109(8):1205-14. doi: 10.1038/ajg.2014.153. Epub 2014 Jun 17.
5
CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer.
Gastroenterology. 2014 Sep;147(3):637-45. doi: 10.1053/j.gastro.2014.05.009. Epub 2014 May 21.
6
Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer.
Gastroenterology. 2014 Aug;147(2):418-29.e8. doi: 10.1053/j.gastro.2014.04.039. Epub 2014 Apr 30.
7
Field cancerization in the colon: a role for aberrant DNA methylation?
Gastroenterol Rep (Oxf). 2014 Feb;2(1):16-20. doi: 10.1093/gastro/got039. Epub 2014 Jan 13.
8
Slug is temporally regulated by cyclin E in cell cycle and controls genome stability.
Oncogene. 2015 Feb 26;34(9):1116-25. doi: 10.1038/onc.2014.58. Epub 2014 Mar 24.
9
Multitarget stool DNA testing for colorectal-cancer screening.
N Engl J Med. 2014 Apr 3;370(14):1287-97. doi: 10.1056/NEJMoa1311194. Epub 2014 Mar 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验